News
The Print on MSN9h
Govt considers low-dose emicizumab for haemophilia, trial finds it more effective than existing treatmentMiracle drug’ can cost Rs 13 lakh for haemophilia A patient annually, but reduced dose found efficacious & cost-effective in ...
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors
NEW YORK, NY, USA I June 26, 2025 I Pfizer Inc. (NYSE: PFE)today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback